Literature DB >> 9585920

Olfaction in persons with Alzheimer's disease.

M D Thompson1, K Knee, C J Golden.   

Abstract

The need for low cost, noninvasive procedures for aiding in the diagnosis and understanding of Alzheimer's Disease (AD) has led to theories and procedures examining the role of olfactory disorders because of the finding that the brains of AD patients invariably exhibit neuropathology in the hippocampus and entorhinal cortex. This loss correlates with the increase in the number of plaques and tangles and with the severity of dementia. Considered together, these findings suggest that brain structures closely related to the olfactory system demonstrate significant histopathology in AD. A comprehensive review of the literature pertaining to olfaction in persons with AD revealed that the olfactory identification ability of patients with memory disorders is impaired relative to controls. Consistency is lacking, however, when olfactory detection thresholds are investigated. Also, there is inconsistency in regards to severity of illness and olfactory function. In addition to differentiating AD patients from normals, the olfactory paradigm has shown some limited usefulness in differentiating AD patients from some other demented patients.

Entities:  

Mesh:

Year:  1998        PMID: 9585920     DOI: 10.1023/a:1025627106073

Source DB:  PubMed          Journal:  Neuropsychol Rev        ISSN: 1040-7308            Impact factor:   7.444


  29 in total

1.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

2.  Olfactory recognition: differential impairments in early and late Huntington's and Alzheimer's diseases.

Authors:  P J Moberg; G D Pearlson; L J Speedie; J R Lipsey; M E Strauss; S E Folstein
Journal:  J Clin Exp Neuropsychol       Date:  1987-12       Impact factor: 2.475

3.  Evaluating storage, retention, and retrieval in disordered memory and learning.

Authors:  H Buschke; P A Fuld
Journal:  Neurology       Date:  1974-11       Impact factor: 9.910

4.  Olfactory deficits and Alzheimer's disease.

Authors:  M D Warner; C A Peabody; J J Flattery; J R Tinklenberg
Journal:  Biol Psychiatry       Date:  1986-01       Impact factor: 13.382

5.  The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases.

Authors:  M C Tierney; R H Fisher; A J Lewis; M L Zorzitto; W G Snow; D W Reid; P Nieuwstraten
Journal:  Neurology       Date:  1988-03       Impact factor: 9.910

6.  The olfactory bulbs in Alzheimer's disease.

Authors:  M M Esiri; G K Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-01       Impact factor: 10.154

7.  Operationalizing memory impairment for elderly persons: the Guild Memory Test.

Authors:  T Crook; J G Gilbert; S Ferris
Journal:  Psychol Rep       Date:  1980-12

8.  The Global Deterioration Scale for assessment of primary degenerative dementia.

Authors:  B Reisberg; S H Ferris; M J de Leon; T Crook
Journal:  Am J Psychiatry       Date:  1982-09       Impact factor: 18.112

9.  Presence of both odor identification and detection deficits in Alzheimer's disease.

Authors:  R L Doty; P F Reyes; T Gregor
Journal:  Brain Res Bull       Date:  1987-05       Impact factor: 4.077

10.  Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration.

Authors:  R L Doty; D A Deems; S Stellar
Journal:  Neurology       Date:  1988-08       Impact factor: 9.910

View more
  10 in total

1.  Deficits in hippocampal-dependent transfer generalization learning accompany synaptic dysfunction in a mouse model of amyloidosis.

Authors:  Karienn S Montgomery; George Edwards; Yona Levites; Ashok Kumar; Catherine E Myers; Mark A Gluck; Barry Setlow; Jennifer L Bizon
Journal:  Hippocampus       Date:  2015-10-19       Impact factor: 3.899

2.  Olfactory identification in non-demented elderly population and in mild cognitive impairment: a comparison of performance in clinical odor identification versus Boston Naming Test.

Authors:  Mikko P Laakso; Susanna Tervo; Tuomo Hänninen; Matti Vanhanen; Merja Hallikainen; Hilkka Soininen
Journal:  J Neural Transm (Vienna)       Date:  2009-05-07       Impact factor: 3.575

Review 3.  Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  J Neural Transm (Vienna)       Date:  2015-05-06       Impact factor: 3.575

Review 4.  Non-cognitive symptoms and related conditions in the Alzheimer's disease: a literature review.

Authors:  Francesco Raudino
Journal:  Neurol Sci       Date:  2013-03-31       Impact factor: 3.307

5.  Cumulative lead exposure is associated with reduced olfactory recognition performance in elderly men: The Normative Aging Study.

Authors:  Rachel Grashow; David Sparrow; Howard Hu; Marc G Weisskopf
Journal:  Neurotoxicology       Date:  2015-06-26       Impact factor: 4.294

6.  In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease.

Authors:  Karen Dell Brown Smith; Verena Kallhoff; Hui Zheng; Robia G Pautler
Journal:  Neuroimage       Date:  2007-02-12       Impact factor: 6.556

7.  Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia.

Authors:  Sung-Jin Park; Jee-Eun Lee; Kwang-Soo Lee; Joong-Seok Kim
Journal:  Neurol Sci       Date:  2018-01-30       Impact factor: 3.307

8.  Large-scale in silico modeling of metabolic interactions between cell types in the human brain.

Authors:  Nathan E Lewis; Gunnar Schramm; Aarash Bordbar; Jan Schellenberger; Michael P Andersen; Jeffrey K Cheng; Nilam Patel; Alex Yee; Randall A Lewis; Roland Eils; Rainer König; Bernhard Ø Palsson
Journal:  Nat Biotechnol       Date:  2010-11-21       Impact factor: 54.908

9.  Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease.

Authors:  Xuesong Chen; Jeremy W Gawryluk; John F Wagener; Othman Ghribi; Jonathan D Geiger
Journal:  J Neuroinflammation       Date:  2008-04-03       Impact factor: 8.322

10.  Amyloid beta inhibits olfactory bulb activity and the ability to smell.

Authors:  Reynaldo Alvarado-Martínez; Karla Salgado-Puga; Fernando Peña-Ortega
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.